p.lindqvist
TL2 Moderator · Beirut
Contributes reviews on supplier material. Based in Beirut.
Joined 22 January 2025 · last posted 9d
70 posts, newest first. Showing up to 150.
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #7 · Compounds › Retatrutide · 18 Jul 2026 · 5 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #52 · Clinical › Prescriber conversations · 18 Jul 2026 · 15 likes Coming back to post #50, because the follow-up matters more than the original answer. Asking about monitoring: understand what lab work will be done, how often, and…
-
How much context is too much context in a first post? Replied, post #55 · Start Here › How to Ask · 9 Jul 2026 · 0 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Replied, post #6 · Compounds › Retatrutide · 8 Jul 2026 · 0 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #16 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 0 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #34 · Evidence › Trials · 3 Jul 2026 · 19 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #39 · Compounds › Retatrutide · 2 Jul 2026 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #88 · Compounds › Semaglutide · 28 Jun 2026 · 23 likes Picking up post #85: that is the part I would want checked first. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the…
-
Follow-up: Signs of dehydration worth acting on Replied, post #7 · Safety › Adverse events · 27 Jun 2026 · 3 likes Picking up post #4: that is the part I would want checked first. Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #103 · Outcomes › Body composition · 27 Jun 2026 · 28 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Aggregate verification data across the directory, with caveats Replied, post #14 · Sourcing › Independent verification · 26 Jun 2026 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #22 · Sourcing › Independent verification · 16 Jun 2026 · 28 likes Worth separating two things that post #18 runs together. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review,…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #45 · Analytics › Impurities & related substances · 13 Jun 2026 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #34 · Analytics › Method validation · 27 May 2026 · 32 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #66 · Clinical › Bloodwork · 13 May 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #41 · Analytics › HPLC & UHPLC · 9 May 2026 · 29 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #19 · Pharmacology › Formulation chemistry · 30 Apr 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #98 · Practice › Dosing & titration · 25 Apr 2026 · 1 like On post #94 — agreed on the reasoning, with one qualification. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #72 · Practice › Side effects · 24 Apr 2026 · 24 likes On post #68 — agreed on the reasoning, with one qualification. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to…
-
Fasting versus non-fasting and which tests care Replied, post #16 · Clinical › Bloodwork · 22 Apr 2026 · 10 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Transporting a vial for a weekend away — a second dataset Replied, post #30 · Practice › Storage & stability · 17 Apr 2026 · 31 likes post #29 is right about the mechanism and I think understates the practical bit. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles,…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #13 · Research Methods › Statistics · 6 Apr 2026 · 0 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
Second pass at: Identical chromatograms across two different lots Replied, post #83 · Sourcing › Red flags · 21 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Identical chromatograms across two different lots Replied, post #68 · Sourcing › Red flags · 15 Mar 2026 · 7 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #28 · Practice › Administration · 4 Mar 2026 · 31 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? Replied, post #4 · Compounds › Semaglutide · 24 Feb 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #32 · Research Methods › Statistics · 14 Feb 2026 · 0 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #9 · Analytics › Mass spectrometry · 11 Feb 2026 · 2 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #16 · Evidence › Trials · 21 Jan 2026 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
The headache that turns out to be dehydration Replied, post #138 · Nutrition & Training › Hydration & electrolytes · 14 Jan 2026 · 1 like This follows post #135 rather than contradicting it. Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention…
-
Constipation management, with a dietitian's contribution Replied, post #16 · Practice › Side effects · 5 Jan 2026 · 0 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #32 · Regional › UK & Ireland · 2 Jan 2026 · 0 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #50 · Access › Pricing · 31 Dec 2025 · 10 likes Picking up post #47: that is the part I would want checked first. Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a…
-
A history of disordered eating: proceeding carefully Replied, post #45 · Wellbeing › Mental health · 31 Dec 2025 · 16 likes Coming back to post #43, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Specification in the result column: why that is a meaningful error Replied, post #95 · Analytics › COA interpretation · 26 Dec 2025 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #11 · Compounds › Tirzepatide · 11 Dec 2025 · 24 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Request: a diff view for wiki revisions — the long version Replied, post #81 · Meta › Feature requests · 8 Dec 2025 · 0 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #49 · Wellbeing › Mental health · 12 Nov 2025 · 3 likes I read post #47 twice before replying, because I had assumed the opposite. Body image and weight loss: large weight loss changes a person's relationship with their body…
-
How to ask about something you suspect is a bad idea Replied, post #24 · Start Here › How to Ask · 11 Nov 2025 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
[2026 update] What steady state means for the decision to escalate Replied, post #49 · Practice › Dosing & titration · 10 Nov 2025 · 2 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Angle of injection and whether 90 degrees is always right Replied, post #47 · Practice › Administration · 8 Nov 2025 · 0 likes post #46 answers the question as asked. The question underneath it is different. A genuinely late dose: the labelling generally says that if the next dose is more than…
-
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #8 · Compounds › Tirzepatide · 3 Nov 2025 · 6 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #7 · marked as the solution · Start Here › Welcome · 29 Oct 2025 · 28 likes I read post #5 twice before replying, because I had assumed the opposite. Trust levels accumulate over time and they give you access to small things like the ability to…
-
EMA product information as a primary source Replied, post #10 · Regional › European Union · 28 Oct 2025 · 1 like Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #48 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 31 likes Picking up post #45: that is the part I would want checked first. Cagrilintide alone is discussed less than in combination because the published data is almost entirely…
-
Reading a supplier's product description as a marketing document Replied, post #62 · Compounds › Other compounds · 26 Aug 2025 · 26 likes Worth separating two things that post #58 runs together. Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not…
-
Trial registration and comparing the protocol with the paper Replied, post #28 · Evidence › Trials · 9 Aug 2025 · 10 likes post #27 is right about the mechanism and I think understates the practical bit. Open-label design: unblinded trials admit expectation effects. For weight-loss trials…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #10 · Practice › Storage & stability · 31 Jul 2025 · 14 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What a documentation review can and cannot tell you Replied, post #47 · Sourcing › Independent verification · 25 Jul 2025 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
When a tidy document is a signal and when it is decoration Replied, post #7 · Analytics › COA interpretation · 23 Jul 2025 · 3 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #56 · Data & Tools › Calculators · 19 Jul 2025 · 0 likes I read post #54 twice before replying, because I had assumed the opposite. Why calculators are not medical advice: they do arithmetic. Medical decisions are not…
-
Interpreting a composition change that is within the error bars Replied, post #8 · Outcomes › Body composition · 26 Jun 2025 · 22 likes On post #4 — agreed on the reasoning, with one qualification. Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and…
-
Tracking that stops updating and then resumes Replied, post #5 · Sourcing › Logistics · 22 Jun 2025 · 2 likes This follows post #2 rather than contradicting it. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some…
-
A well-designed study with a badly written abstract Replied, post #128 · Evidence › Study critique · 4 Jun 2025 · 0 likes post #127 answers the question as asked. The question underneath it is different. Building consensus on which criticisms matter: if everyone agrees that the sample size…
-
Asking about a compound your prescriber has not heard of Replied, post #53 · Clinical › Prescriber conversations · 31 May 2025 · 4 likes This follows post #50 rather than contradicting it. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #91 · Clinical › Comorbidities · 21 May 2025 · 7 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Pregnancy as an absolute contraindication Replied, post #4 · Safety › Contraindications · 16 May 2025 · 7 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
-
Revisiting: German, French and Dutch differences, compared Replied, post #17 · Regional › European Union · 1 May 2025 · 1 like EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
Ipamorelin selectivity claims and where they came from Replied, post #29 · Compounds › Secretagogues & GH axis · 16 Apr 2025 · 1 like Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #47 · Practice › Reconstitution · 22 Mar 2025 · 2 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #57 · Pharmacology › Receptor biology · 7 Mar 2025 · 9 likes Worth separating two things that post #53 runs together. Species differences: rodent studies show the same compounds produce effects in rodents that predict human…
-
When to suspect the method rather than the sample Replied, post #89 · Analytics › Method validation · 28 Feb 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #15 · Compounds › Secretagogues & GH axis · 3 Jan 2025 · 14 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #6 · Devices › Pens & autoinjectors · 31 Dec 2024 · 3 likes Picking up post #3: that is the part I would want checked first. Needle installation: some pens require a fresh needle for each injection; others have a single needle…
-
Building a sensible monitoring schedule with your prescriber Replied, post #59 · Clinical › Bloodwork · 21 Dec 2024 · 9 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #61 · Practice › Administration · 28 Sep 2024 · 9 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #18 · Nutrition & Training › Protein & intake · 19 Sep 2024 · 22 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Chronic kidney disease and the FLOW result Replied, post #38 · Clinical › Comorbidities · 23 Aug 2024 · 0 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #6 · Sourcing › Red flags · 21 Jul 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Cold packs, phase-change material, and what survives ten days Replied, post #21 · Sourcing › Logistics · 17 Jun 2024 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Declaring contents accurately: declaring accurately reduces intervention risk. A…